1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Arrhythmia in 26 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 9 (34.62) | 18.7374 |
1990's | 14 (53.85) | 18.2507 |
2000's | 1 (3.85) | 29.6817 |
2010's | 2 (7.69) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gu, CD; Shi, J; Sun, HT; Tao, YK; Yu, PL; Zhang, GQ; Zhao, SP | 1 |
Borja, J; Fité, R | 1 |
Burke, JA; Guo, ZG; Hanahan, DJ; Hattori, Y; Hoppens, CM; Levi, R; McManus, LM; Pinckard, RN | 1 |
Abacioğlu, N; Cakici, I; Ersoy, S; Kanzik, I; Mataraci, N; Tunçtan, B | 1 |
Flores, NA; Goulielmos, NV; Seghatchian, MJ; Sheridan, DJ | 1 |
Feinmark, SJ; Guo, SD; Hoffman, BF | 1 |
Ansley, DM; English, JC; Godin, DV; Kim, CW; Lee, JU; Loucks, EB; Qayumi, AK | 1 |
Cakici, I; Kanzik, I; Sariahmetoğlu, M | 1 |
Barbuti, A; Feinmark, SJ; Ishii, S; Robinson, RB; Shimizu, T | 1 |
Chakrabarty, S; Flores, NA; Fluck, DS; Sheridan, DJ | 1 |
Leong, LL; Papadimitriou, JM; Stephens, CJ; Sturm, MJ; Taylor, RR | 1 |
Ahmad, Z; Baumann, G; Berdel, WE; Felix, SB; Hashemi, T; Niemczyk, M | 1 |
Barrigón, S; Salinas, P | 1 |
Braquet, P; Esanu, A; Hosford, D; Koltai, M; Tosaki, A | 1 |
Chakrabarty, S; Sheridan, DJ; Thomas, P | 1 |
Flores, NA; Seghatchian, MJ; Sheridan, DJ | 1 |
Flores, NA; Sheridan, DJ | 1 |
Coyle, DE; Sperelakis, N; Wahler, GM | 1 |
Braquet, P; Hosford, D; Koltai, M; Tosaki, A | 1 |
Hoffmann, IH; Mentz, G; Mentz, P; Mest, HJ; Meyer, E; Riedel, A; Sperling, J; Tschorn, W | 1 |
Demopoulos, CA; Evangelou, A; Kapoulas, VM; Tselepis, AD; Tsoukatos, D | 1 |
Mest, HJ; Riedel, A | 1 |
Alloatti, G; Camussi, G; Emanuelli, G; Mariano, F; Meda, E; Montrucchio, G; Tetta, C | 1 |
Braquet, P; Mest, HJ; Meyer, E; Riedel, A | 1 |
Mest, HJ; Riedel, A; Schneider, S | 1 |
Braquet, P; Mest, HJ; Riedel, A | 1 |
26 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Arrhythmia
Article | Year |
---|---|
Elevated platelet activating factor level in ischemia-related arrhythmia and its electrophysiological effect on myocardium.
Topics: Animals; Arrhythmias, Cardiac; Electrocardiography; Female; Heart; Humans; Male; Middle Aged; Myocardial Ischemia; Platelet Activating Factor; Swine | 2013 |
Rupatadine and heart rhythm disturbances.
Topics: Arrhythmias, Cardiac; Cyproheptadine; Humans; Platelet Activating Factor | 2010 |
Acetyl glyceryl ether phosphorylcholine (AGEPC). A putative mediator of cardiac anaphylaxis in the guinea pig.
Topics: Anaphylaxis; Animals; Arrhythmias, Cardiac; Coronary Circulation; Coronary Vessels; Guinea Pigs; Heart; Heart Ventricles; Male; Myocardial Contraction; Platelet Activating Factor | 1984 |
Effects of platelet-activating factor antagonists WEB 2086 and BN 50730 on digoxin-induced arrhythmias.
Topics: Animals; Arrhythmias, Cardiac; Azepines; Digoxin; Female; Guinea Pigs; Hemodynamics; Male; Platelet Activating Factor; Platelet Aggregation Inhibitors; Thienopyridines; Triazoles | 1995 |
Myocardial ischaemia induces platelet activation with adverse electrophysiological and arrhythmogenic effects.
Topics: Animals; Arrhythmias, Cardiac; Aspirin; Biphenyl Compounds; Blood Platelets; Colforsin; Diterpenes; Electrophysiology; Ginkgolides; Guinea Pigs; Heart; Heptanoic Acids; Lactones; Male; Myocardial Ischemia; Oxidopamine; Platelet Activating Factor; Platelet Activation; Platelet Aggregation Inhibitors; Receptors, Thromboxane; Yohimbine | 1994 |
Arrhythmias caused by platelet activating factor.
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Dogs; Dose-Response Relationship, Drug; Female; Lidocaine; Male; Membrane Potentials; Patch-Clamp Techniques; Platelet Activating Factor; Platelet Membrane Glycoproteins; Pyridinium Compounds; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Tetrodotoxin | 1996 |
The role of platelet-activating factor in regional myocardial ischemia-reperfusion injury.
Topics: Animals; Arrhythmias, Cardiac; Atrial Fibrillation; Blood Pressure; Cardiac Output; Cardiac Volume; Disease Models, Animal; Female; Heart Arrest; Hemodynamics; Isoquinolines; Myocardial Contraction; Myocardial Infarction; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocardium; Neutrophils; Platelet Activating Factor; Platelet Aggregation Inhibitors; Pyridinium Compounds; Random Allocation; Stroke Volume; Swine; Tetrahydroisoquinolines; Ventricular Fibrillation; Ventricular Function | 1998 |
Effects of WEB 2086 on the protective role of preconditioning against arrhythmias in rats.
Topics: Animals; Arrhythmias, Cardiac; Azepines; Hemodynamics; Ischemic Preconditioning; Male; Platelet Activating Factor; Rats; Triazoles | 1998 |
Block of the background K(+) channel TASK-1 contributes to arrhythmogenic effects of platelet-activating factor.
Topics: Action Potentials; Animals; Arachidonic Acids; Arrhythmias, Cardiac; Barium; Electric Conductivity; Electrophysiology; Enzyme Inhibitors; Heart; Heart Ventricles; Membrane Potentials; Mice; Mice, Knockout; Nerve Tissue Proteins; Phospholipid Ethers; Platelet Activating Factor; Platelet Membrane Glycoproteins; Potassium Channel Blockers; Potassium Channels; Potassium Channels, Tandem Pore Domain; Protein Kinase C; Protons; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Zinc | 2002 |
Effects of the PAF antagonists BN50726 and BN50739 on arrhythmogenesis and extent of necrosis during myocardial ischaemia/reperfusion in rabbits.
Topics: Animals; Arrhythmias, Cardiac; Azepines; Blood Pressure; Electrocardiography; Heart Rate; Hemodynamics; Myocardial Infarction; Myocardial Ischemia; Myocardial Reperfusion Injury; Necrosis; Platelet Activating Factor; Rabbits; Thienopyridines; Triazoles | 1992 |
The effects of a PAF antagonist on ischemic myocardial damage and arrhythmia in the dog.
Topics: Animals; Arrhythmias, Cardiac; Azepines; Coronary Disease; Dogs; Myocardial Reperfusion Injury; Platelet Activating Factor; Tachycardia; Triazoles; Ventricular Fibrillation | 1992 |
Characterization of cardiovascular events mediated by platelet activating factor during systemic anaphylaxis.
Topics: Anaphylaxis; Animals; Arrhythmias, Cardiac; Azepines; Blood Pressure; Cardiac Output; Cimetidine; Electrocardiography; Female; Guinea Pigs; Heart Rate; Hemodynamics; Histamine; Male; Myocardial Contraction; Ovalbumin; Platelet Activating Factor; Pyrilamine; Triazoles | 1990 |
Protective effects of dazmegrel on the PAF potential of ouabain-induced cardiac arrhythmias.
Topics: Animals; Arrhythmias, Cardiac; Aspirin; Disease Models, Animal; Drug Synergism; Female; Guinea Pigs; Imidazoles; Lysine; Ouabain; Platelet Activating Factor; Thromboxane-A Synthase | 1991 |
Effect of BN 50739, a new platelet activating factor antagonist, on ischaemia induced ventricular arrhythmias in isolated working rat hearts.
Topics: Animals; Arrhythmias, Cardiac; Azepines; Coronary Disease; Dose-Response Relationship, Drug; Heart; Heart Ventricles; Male; Myocardial Reperfusion; Organ Culture Techniques; Platelet Activating Factor; Rats; Rats, Inbred Strains; Triazoles | 1991 |
Contribution of platelets and platelet-activating factor (PAF) to the arrhythmogenic, haemodynamic and necrotic effects of acute myocardial ischaemia.
Topics: Animals; Arrhythmias, Cardiac; Blood Platelets; Diterpenes; Ginkgolides; Hypotension; Imidazoles; Immune Sera; Lactones; Myocardial Infarction; Necrosis; Platelet Activating Factor; Platelet Activation; Pyridines; Rabbits; Thromboxane A2; Thromboxane-A Synthase | 1991 |
Platelet-mediated alterations in cardiac cellular electrophysiology.
Topics: Action Potentials; Animals; Arrhythmias, Cardiac; Blood Platelets; Coronary Disease; Electrophysiology; Guinea Pigs; Heart; Male; Platelet Activating Factor; Platelet Activation | 1991 |
Electrophysiological and arrhythmogenic effects of platelet activating factor during normal perfusion, myocardial ischaemia and reperfusion in the guinea-pig.
Topics: Animals; Arrhythmias, Cardiac; Coronary Disease; Electrophysiology; Guinea Pigs; Heart; In Vitro Techniques; Male; Myocardial Reperfusion Injury; Perfusion; Platelet Activating Factor; Ventricular Fibrillation | 1990 |
Effects of platelet-activating factor on single potassium channel currents in guinea pig ventricular myocytes.
Topics: Animals; Arrhythmias, Cardiac; Guinea Pigs; Heart Ventricles; In Vitro Techniques; Platelet Activating Factor; Potassium Channels | 1990 |
Ginkgolide B protects isolated hearts against arrhythmias induced by ischemia but not reperfusion.
Topics: Animals; Arrhythmias, Cardiac; Diltiazem; Diterpenes; Ginkgolides; Heart Function Tests; Lactones; Male; Metoprolol; Myocardial Reperfusion; Perfusion; Platelet Activating Factor; Rats; Rats, Inbred Strains; Reperfusion Injury | 1989 |
The relevance of eicosanoids including PAF for the biochemical regulation of cardiac rhythm.
Topics: Alprostadil; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Azepines; Diterpenes; Dogs; Fatty Acids, Unsaturated; Female; Ginkgolides; Guinea Pigs; Heart Rate; In Vitro Techniques; Lactones; Male; Platelet Activating Factor; Sulfonamides; Triazines; Triazoles | 1989 |
Electrocardiographic alterations induced by AGEPC in Wistar rats in relation to its hypotensive and hematologic effects.
Topics: Animals; Arrhythmias, Cardiac; Blood Pressure; Electrocardiography; Heart; Hematocrit; Leukocyte Count; Male; Neutrophils; Platelet Activating Factor; Rats; Rats, Inbred Strains | 1987 |
The effect of PAF (platelet-activating factor) on experimental cardiac arrhythmias and its inhibition by substances influencing arachidonic acid metabolites.
Topics: Animals; Arachidonic Acids; Arrhythmias, Cardiac; Aspirin; Fibrinolytic Agents; Guinea Pigs; Lipoxygenase Inhibitors; Ouabain; Platelet Activating Factor; Sulfonamides; Umbelliferones | 1987 |
The pattern of cardiovascular alterations induced by infusion of platelet-activating factor in rabbit is modified by pretreatment with H1-H2 receptor antagonists but not by cyclooxygenase inhibition.
Topics: Animals; Arrhythmias, Cardiac; Cimetidine; Cyclooxygenase Inhibitors; Drug Interactions; Electrocardiography; Female; Hemodynamics; Histamine; Histamine Antagonists; Indomethacin; Infusions, Intravenous; Male; Platelet Activating Factor; Promethazine; Rabbits | 1987 |
The arrhythmogenic effect of platelet activating factor (PAF) is inhibited by PAF antagonist and by substances influencing eicosanoids.
Topics: Aconitic Acid; Animals; Arrhythmias, Cardiac; Diazepam; Diltiazem; Dogs; Guinea Pigs; Imidazoles; Myocardial Contraction; Naphthalenes; Ouabain; Platelet Activating Factor; Pyrimidines; Rats; Reference Values; Trapidil | 1988 |
Relevance of eicosanoids for biochemical regulation of cardiac rhythm disturbances.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Arrhythmias, Cardiac; Epoprostenol; Fatty Acids, Unsaturated; Guinea Pigs; Male; Platelet Activating Factor; Prostaglandin Endoperoxides, Synthetic; Rats; Rats, Inbred Strains; Sulfonamides; Thromboxanes | 1987 |
The effect of the specific PAF antagonist BN 52021 and the calcium blocker diltiazem on PAF induced arrhythmogenicity.
Topics: Administration, Oral; Animals; Arrhythmias, Cardiac; Diltiazem; Diterpenes; Ginkgolides; Guinea Pigs; In Vitro Techniques; Injections, Intravenous; Lactones; Ouabain; Platelet Activating Factor | 1987 |